Non-interventional, Prospective Study to Determine Prevalence of EGFR Mutations in Non-small Cell Lung Cancer

Clinical trial NCT04742192 · COMPLETED

Trial details

NCT number: NCT04742192
Sponsor: AstraZeneca
Status: COMPLETED
Study type: OBSERVATIONAL

Non-small Cell Lung Cancer

Start date: 2021-03-04
Primary completion: 2022-11-30
Enrollment: 601

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.